Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Total Liabilities 2009–2025
Lexicon Pharmaceuticals, Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Lexicon Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 77.4M, a 49.20% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. total liabilities for 2025 were 77.4M, a 49.20% decrease from 2024.
- Lexicon Pharmaceuticals, Inc. total liabilities for 2024 were 152.5M, a 11.85% increase from 2023.
- Lexicon Pharmaceuticals, Inc. total liabilities for 2023 were 136.3M, a 76.64% increase from 2022.
- Lexicon Pharmaceuticals, Inc. total liabilities for 2022 were 77.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lexicon Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $77 |
| 2024 | $152 |
| 2023 | $136 |
| 2022 | $77 |
| 2021 | $23 |
| 2020 | $47 |
| 2019 | $301 |
| 2018 | $311 |
| 2017 | $368 |
| 2016 | $318 |
| 2015 | $366 |
| 2014 | $187 |
| 2013 | $104 |
| 2012 | $105 |
| 2011 | $133 |
Lexicon Pharmaceuticals, Inc. Total Liabilities — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LXRX's total liabilities history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.